Resident scholar at The American Enterprise Institute for Public Policy Research
- Healthcare provisions listed in the Inflation Reduction Act and its potential impact on the pharmaceutical and biotechnology industries
- Short- vs long-term implications of the law and outlook for how policies will be implemented
- Analysis of CBO (Congressional Budget Office) scoring
- Drug pricing, contracts and potential legal challenges from the pharmaceutical and biotechnology industries
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.